PL402470A1 - Enhancing composition flexibility of the blood vessels of the eye - Google Patents
Enhancing composition flexibility of the blood vessels of the eyeInfo
- Publication number
- PL402470A1 PL402470A1 PL402470A PL40247013A PL402470A1 PL 402470 A1 PL402470 A1 PL 402470A1 PL 402470 A PL402470 A PL 402470A PL 40247013 A PL40247013 A PL 40247013A PL 402470 A1 PL402470 A1 PL 402470A1
- Authority
- PL
- Poland
- Prior art keywords
- amount
- weight
- blueberry
- vitamin
- eye
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Kompozycja do podawania doustnego zawiera ekstrakt z owoców borówki czernicy w ilości 90-98% wag., rutynę w ilości 1-5% wag., trokserutynę w ilości 1-5% wag., a ponadto zawiera co najmniej jeden składnik wybrany z grupy zawierającej: witaminę C, w ilości 5-15% wag., witaminę E w ilości 1-5% wag., sól cynku w ilości 1-5% wag. w przeliczeniu na cynk, witaminę B6 w ilości 0,1-2% wag. i witaminę B2 w ilości 0,1-2% wag., gdzie udział składników dodatkowych jest podany w stosunku do łącznej masy ekstraktu z borówki czernicy, rutyny i trokserutyny, przy czym zawartość antocyjanów w ekstrakcie z owoców borówki czernicy zawiera się w przedziale 20-30%, a dzienna dawka kompozycji zawiera od 99 do 600 mg antocyjanów.The composition for oral administration contains blueberry fruit extract in an amount of 90-98% by weight, routine in an amount of 1-5% by weight, troxerutin in an amount of 1-5% by weight, and furthermore contains at least one ingredient selected from the group consisting of : vitamin C in an amount of 5-15% by weight, vitamin E in an amount of 1-5% by weight, zinc salt in an amount of 1-5% by weight calculated as zinc, vitamin B6 in an amount of 0.1-2 wt. and vitamin B2 in an amount of 0.1-2% by weight, where the proportion of additional ingredients is given in relation to the total weight of blueberry, blueberry, routine and troxerutin extract, the anthocyanin content of blueberry blueberry extract being in the range of 20 30%, and the daily dose of the composition contains from 99 to 600 mg of anthocyanins.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL402470A PL220788B1 (en) | 2013-01-18 | 2013-01-18 | Enhancing composition flexibility of the blood vessels of the eye |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL402470A PL220788B1 (en) | 2013-01-18 | 2013-01-18 | Enhancing composition flexibility of the blood vessels of the eye |
Publications (2)
Publication Number | Publication Date |
---|---|
PL402470A1 true PL402470A1 (en) | 2014-07-21 |
PL220788B1 PL220788B1 (en) | 2016-01-29 |
Family
ID=51179311
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL402470A PL220788B1 (en) | 2013-01-18 | 2013-01-18 | Enhancing composition flexibility of the blood vessels of the eye |
Country Status (1)
Country | Link |
---|---|
PL (1) | PL220788B1 (en) |
-
2013
- 2013-01-18 PL PL402470A patent/PL220788B1/en unknown
Also Published As
Publication number | Publication date |
---|---|
PL220788B1 (en) | 2016-01-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1120628T1 (en) | FLAVONID BASED COMPOSITION FOR PHARMACEUTICAL, NUTRITIONAL OR COSMETIC USE THAT HAVE ENHANCED ANTIOXIDANT ACTION | |
AR098882A1 (en) | DENTAL COMPOSITION THAT INCLUDES ZINC OXIDE AND ZINC CITRATE | |
AR052851A1 (en) | OXIDATION RESISTANT DENTIFRIC COMPOSITIONS | |
MX2011012547A (en) | Green tea extracts of improved bioavailability. | |
BR112015014480A2 (en) | stable compositions containing metal ions | |
MX2019008650A (en) | Stable and liposoluble active ingredient composition, microcapsule, and preparation method and application thereof. | |
BR112014003640A2 (en) | weight loss methods and ketogenic compositions | |
BR112012019997A2 (en) | oral care compositions | |
MX357554B (en) | Aloe vera sprout concentrate or extract having superior skin cell growth promotion, antioxidant, and anti-allergy effects. | |
ECSP13012799A (en) | USE OF NUTRITIONAL COMPOSITIONS THAT INCLUDE LACTOFERRINS TO IMPROVE RESISTANCE TO DISEASES AND CONDITIONS | |
BR112012026346A2 (en) | Innovative formulations of active ingredients (s) of vegetable origin or their synthetic analogs or extracts thereof including vegetable lacitin | |
UA75461U (en) | Medicine for the prevention of dental diseases | |
GB201310235D0 (en) | Nutraceutical and pharmaceutical composition | |
BR112015027991A2 (en) | petroselinic acid or combination of active ingredients, comprising at least petroselinic acid to promote weight loss and / or weight maintenance | |
MX2014014579A (en) | O/w-emulsion-type topical pharmaceutical compositions containing a retinoid. | |
BR112013026933A2 (en) | use of a combination of at least one carotenoid | |
WO2014006635A3 (en) | Solid oral compositions of silodosin | |
PL402470A1 (en) | Enhancing composition flexibility of the blood vessels of the eye | |
MY170724A (en) | Use of certain trioxygenated benzene derivatives in body fat management | |
GEP20196957B (en) | Crystalline forms of s-acetyl glutathione, their reparations and uses in pharmaceutical and nutraceutical formulations | |
RU2014146562A (en) | ALPHA-LIPOIC ACID AND RACNOCIOLE COMPOSITION FOR THE TREATMENT OF NEUROPATHIES | |
MX2015007347A (en) | Gel compositions. | |
PL426617A1 (en) | Dietary supplement | |
PL405875A1 (en) | Dietary supplement | |
PL408434A1 (en) | Dietary food product used in nephrolithiasis |